MRK Jun 2024 129.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.2000

+0.0900

(+4.27%)

At close: 03:59PM EDT

Simply Wall St.
With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Merck's stock price might be vulnerable to their...
Yahoo Finance Video
FDA approves Merck's pneumonia vaccine for adults
The Food and Drug Administration (FDA) has approved Merck's (MRK) new vaccine to protect adults from pneumonia. Yahoo Finance's Anjalee Khemlani reports more on how the vaccine works as the pharmaceutical company awaits the Centers for Disease Control's (CDC) recommendation. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl
Zacks
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV specifically designed for adults to be approved by the FDA.